Apath

What Apath does

Apath, LLC was a privately held, New York-based technology licensing company founded in approximately 1996 by Dr. Charles M. Rice and Robert M. Roth. It operated in the commercial application of virology and viral genetics, supplying research and development tools to academic, non-profit, and commercial researchers conducting virology research, with specific attribution to enabling breakthroughs that led to the cure of hepatitis C virus infections. The underlying technology centered on specialized virology R&D tools and reagents; no product catalog, platform architecture, or proprietary feature set is detailed in the source material.

The business was structured as a closely held LLC with no disclosed external institutional investors, parent company, or subsidiaries, and no public pricing, revenue model, or headcount information. Its customer base was segmented horizontally across three researcher personas — academic, non-profit, and commercial — with hepatitis C virus research highlighted as a primary use case for the academic segment. The company operated independently for nearly three decades before its co-founders announced the conclusion of all business operations effective May 31, 2025, after which product and technical support ceased and academic research inquiries were redirected to The Rice Lab, Laboratory of Virology and Infectious Disease, at The Rockefeller University.

Name

Apath

Legal name

Apath, LLC

Website

https://apath.com

Company type

Private

Founded year

1996

Operating status

Closed

Headcount range

51–100 employees

Short description

Apath, LLC was a privately held New York-based technology licensing company, founded circa 1996 by Dr. Charles M. Rice and Robert M. Roth, that supplied virology research and development tools to academic, non-profit, and commercial researchers before ceasing all operations on May 31, 2025.

Ownership category

akta.pro rank

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations

Core offering

Apath, LLC provided research and development tools used by virology researchers in academic, non-profit, and commercial settings. The company was engaged in the commercial application of virology and viral genetics, licensing its tools to scientific investigators. Its offerings contributed to breakthroughs that led to the cure of hepatitis C virus infections and advanced the field of virology over nearly three decades of operation.

Product overview

Apath, LLC was a research and development tools company that served the scientific community for nearly three decades, providing tools for academic, non-profit, and commercial researchers. The company supported virology research and contributed to breakthroughs that led to the cure of hepatitis C virus infections. The company ceased all business operations effective May 31, 2025.

Differentiator

Problem solved

Functional benefit

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• The Rice Lab, Laboratory of Virology and Infectious Disease, The Rockefeller UniversityminorOthers · 31 May 2025Following Apath's closure announcement, academic research inquiries were directed to The Rice Lab at The Rockefeller University. This represents a post-closure referral relationship rather than an active partnership, facilitating continuity for academic researchers who previously worked with Apath.

Scale indicators1 record

Recent moves3 records

Expansion highlights1 record

Broad incumbents

• Integrated DNA Technologies (IDT): Major provider of nucleic acid products including oligonucleotides, probes, and基因合成 reagents widely used in virology research. Comparable as a foundational research tools supplier serving academic, non-profit, and commercial researchers.
• Bio-Techne: Manufacturer of purified proteins, antibodies, and reagents for life sciences research, including infectious disease and viral research applications. Comparable as a broad incumbent in the biological research tools category.
• Thermo Fisher Scientific: Largest life sciences tools company globally, offering cell culture media, viral production services, reagents, and instrumentation. Comparable as the dominant broad incumbent serving virology and infectious disease researchers across academic and commercial segments.
• Aldevron: Manufacturer of biologics, plasmids, mRNA, and recombinant proteins for research and clinical use. Comparable life-sciences tools supplier operating at greater scale across the virology and gene therapy research continuum.

Direct peers

• Addgene: Non-profit plasmid repository distributing research-ready genetic materials to scientists worldwide. Comparable to Apath as a long-running research tools platform that supports virology and molecular biology investigations.
• ATCC (American Type Culture Collection): Non-profit global biorepository supplying authenticated cell lines, microbial cultures, and biological reagents to academic and commercial researchers. Closely comparable to Apath as a long-standing virology/infectious-disease research tools provider serving the same scientific customer base.
• BEI Resources: NIAID-supported repository distributing bacterial and viral reference reagents to the research community. Comparable as a virology/pathogen research tools supplier serving academic and government researchers.
• ZeptoMetrix: Specialty manufacturer of viral antigens, inactivated and live viruses, and infectious disease reagents for diagnostics and research. Directly comparable to Apath's virology research tools business model.

Market position

Weaknesses3 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/apath

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Apath